Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
---|---|---|---|---|---|---|---|---|---|---|---|
JYSZ1300052 | 口服乳杆菌LB散 | Recombinant Human Endostatin | Powder | Biological Products | License Renew | 2013-12-03 | APTALIS PHARMA SAS | Aptalis Pharma SAS | Certificate Issued | 2019-10-10 | view |
JYSZ1300053 | 口服乳杆菌LB散 | Recombinant Human Endostatin | Powder | Biological Products | License Renew | 2013-11-22 | APTALIS PHARMA SAS | Aptalis Pharma SAS | Certificate Issued | 2019-10-10 | view |
JYSZ1200054 | 口服乳杆菌LB胶囊 | Capsule | Biological Products | License Renew | 2012-10-30 | APTALIS PHARMA SAS | Aptalis Pharma SAS | Certificate Issued | 2013-09-02 | view | |
JYSZ1200055 | 口服乳杆菌LB胶囊 | Capsule | Biological Products | License Renew | 2012-10-23 | APTALIS PHARMA SAS | Aptalis Pharma SAS | Certificate Issued | 2013-09-02 | view |